Loading clinical trials...
Loading clinical trials...
This study is being conducted to see if the investigational medication, valopicitabine, is safe to use in combination with ribavirin, a drug approved by the FDA for treating hepatitis C infection.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Merck Sharp & Dohme LLC
Collaborators
NCT06180590 · Chronic Hepatitis C, Medication Reaction
NCT03993925 · Chronic Hepatitis C, Intravenous Drug Usage
NCT00199719 · Chronic Hepatitis C
NCT06922643 · Chronic Hepatitis C
NCT02578693 · Chronic Hepatitis C Infection
Atlanta, Georgia
Fairfax, Virginia
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions